• Pharmacology
  • Allergy, Immunology, and ENT
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious Diseases
  • Neurology
  • OB/GYN
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Mental, Behavioral and Development Health
  • Oncology
  • Rheumatology
  • Sexual Health
  • Pain

FDA update on Chinese infant formula contamination

Article

A U.S. Food and Drug Administration (FDA) investigation of more than 1,000 retail markets which may have brought Chinese infant formula into the U.S. yielded no such items, the FDA stated.

A U.S. Food and Drug Administration (FDA) investigation of more than 1,000 retail markets which may have brought Chinese infant formula into the U.S. yielded no such items, the FDA stated.

The FDA had previously advised on September 12 that consumers should not purchase any baby formula from China, after Chinese officials reported that a tainted, milk-based formula led to the death of one baby and may have caused kidney stones in dozens of others.

Since then, the melamine-tainted formula has been linked to nearly 53,000 sickened infants, nearly 13,000 hospitalizations, and four infant deaths, according to the Associated Press.

Related Videos
Reducing HIV reservoirs in neonates with very early antiretroviral therapy | Deborah Persaud, MD
Deborah Persaud, MD
Breaking down toddler formulas and the confusion associated with naming, labeling | Image Credit: © University of Kentucky - © University of Kentucky - stock.adobe.com.
infant formula
Related Content
© 2024 MJH Life Sciences

All rights reserved.